Live Webinar: Is Your Pharma Strategy Ready for the AI-Empowered HCP? Join Viz.ai, Salesforce, and Pfizer on 9/16 at 12:30 pm ET.

Viz™ ANEURYSM

A Retrospective Evaluation of the Potential Impact on an Artificial Intelligence-Based Software on the Detection and Follow-Up of Unruptured Intracranial Aneurysms

In a retrospective evaluation across 11 hospitals over 5 months (1777 consecutive CTAs for stroke evaluation), 55% of AI-identified cases were not detected in routine clinical care, and 75% of cases were not referred for follow up.

Researcher:

Mike Stiefel et al.

Published:

Apr 21, 2023